UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000005872 |
|---|---|
| Receipt number | R000006905 |
| Scientific Title | A Phase 2 Study of Carboplatin, Pemetrexed, and Bevacizumab followed by Bevacizumab and Erlotinib maintenance for Non-squamous Non-Small Cell Lung Cancer not harboring EGFR mutations. (HOT1101) |
| Date of disclosure of the study information | 2011/06/28 |
| Last modified on | 2017/01/04 13:10:34 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/06/28 22:06:19 | ||
| 2 | Update | 2013/12/28 14:48:14 | TEL |
|
| 3 | Update | 2017/01/04 13:07:59 | Control |
|
| 4 | Update | 2017/01/04 13:09:24 | Name of primary person or sponsor Organization Organization Division |
|
| 5 | Update | 2017/01/04 13:10:34 | Recruitment status Date of protocol fixation Publication of results |
